First Manhattan’s CONMED CNMD Stock Holding History

First Manhattan’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000	Closed	-$58K	–	1432
2015 Q2	$58K	Hold	1,000	–	–	﹤0.01%	936
2015 Q1	$50K	Hold	1,000	–	–	﹤0.01%	970
2014 Q4	$44K	Hold	1,000	–	–	﹤0.01%	1007
2014 Q3	$36K	Hold	1,000	–	–	﹤0.01%	1020
2014 Q2	$44K	Hold	1,000	–	–	﹤0.01%	984
2014 Q1	$43K	Buy	+1,000	New	+$44.6K	﹤0.01%	980

Other funds holding CNMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Coppersmith Capital Management New York $105M AUM 8.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

First Manhattan's CNMD Position: Q3 2015 in Review

First Manhattan sold out of CONMED (CNMD) in Q3 2015, closing a stake of 1,000 shares — an estimated $58K sold.

First Manhattan first reported a position in CNMD in Q1 2014 and held it in 6 quarters. The position peaked at $58K in Q2 2015. 157 funds tracked by Wall St. Rank hold CNMD as of Q3 2015.

First Manhattan reported no remaining CONMED position as of Q3 2015 after selling out during the quarter.
First Manhattan sold 1,000 CONMED shares in Q3 2015, an estimated $58K.
First Manhattan first reported a position in CONMED in Q1 2014 and held it in 6 quarters.
First Manhattan's CONMED position peaked at $58K in Q2 2015.
157 funds tracked by Wall St. Rank held CONMED as of Q3 2015.

Based on First Manhattan's 13F filing for Q3 2015, filed 26 Oct 2015.